SCHEMBL3737883

SCHEMBL3737883

COc1ccc(-c2c(O)nc3ccccc3c2C(=O)O)cc1

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.54
DHODH Q02127 3/20 0.52
ALDH1A1 P00352 5/20 0.52
NPC1 O15118 3/20 0.52
RAB9A P51151 3/20 0.52
HPGD P15428 3/20 0.52
KDM4E B2RXH2 3/20 0.52
MAPT P10636 3/20 0.52
SMN1; SMN2 Q16637 2/20 0.52
NFKB1 P19838 1/20 0.52
NFKB2 Q00653 1/20 0.52
RELA Q04206 1/20 0.52
ATM Q13315 1/20 0.52
NPSR1 Q6W5P4 1/20 0.52
MEN1 O00255 1/20 0.50
KMT2A Q03164 1/20 0.50
PADI4 Q9UM07 1/20 0.49
HTT P42858 2/20 0.48
CYP1A2 P05177 1/20 0.48
CYP3A4 P08684 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3743372 0.85 LMNA (0.71) LMNADHODHKDM4EMAPTSMN1; SMN2
SCHEMBL3750345 0.83 DHODH (0.54) DHODHALDH1A1NPC1RAB9AHPGD
SCHEMBL21451029 0.82 LMNA (0.57) LMNADHODHNPC1RAB9AKDM4E
SCHEMBL16895273 0.82 LMNA (0.57) LMNADHODHCYP3A4CYP2C9
SCHEMBL28117783 0.78 LMNA (0.54) LMNADHODHALDH1A1NPC1HPGD
SCHEMBL3737884 0.78 NPC1 (0.56) LMNADHODHALDH1A1NPC1RAB9A
SCHEMBL304562 0.76 KDM4E (0.61) LMNAALDH1A1NPC1RAB9AHPGD
SCHEMBL10467326 0.76 DHODH (0.59) LMNADHODHALDH1A1HPGDKDM4E
SCHEMBL9639864 0.75 GFER (0.52) LMNAALDH1A1NPC1RAB9AHPGD
SCHEMBL3036200 0.74 KDM4E (0.56) LMNADHODHALDH1A1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106279021-A One class Antibiotic FR 901228 based on indeno quinolinone skeleton and its preparation method and application 中国人民解放军第二军医大学 2017-01-04 CN disclosed
US-7829567-B2 Imino-indeno[1,2-c] quinoline derivatives, their preparation processes, and pharmaceutical compositions comprising the same KAOHSIUNG MEDICAL UNIVERSITY (TW) 2010-11-09 US disclosed
US-20090111987-A1 Imino-Indeno[1,2-c] quinoline derivatives, their preparation processes, and pharmaceutical compositions comprising the same KAOHSIUNG MEDICAL UNIVERSITY (TW) 2009-04-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090111987-A1 Imino-Indeno[1,2-c] quinoline derivatives, their preparation processes, and pharmaceutical compositions comprising the same IMPA1, IMPDH1, IPO5 LMNA 714/4885DHODH 360/4885ALDH1A1 324/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.